Erica Farrand, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue, #M1083A
San Francisco CA 94117
Phone415-476-8067
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Columbia UniversitySchool of Medicine2010
    NYP-Columbia UniversityInternal Medicine2013
    University of California, San FranciscoPulmonary and Critical Care2019
    University of California, San Francisco2020Diversity, Equity, and Inclusion Champion Training
    University of California, San Francisco2019Advanced Training in Clinical Research Certificate
    Collapse awards and honors
    The American Society for Clinical Investigation2025Young Physician Scientist Award
    University of California San Francisco2024Michael Stulbarg Excellence in Teaching Award
    UCSF Institute for Health Policy2023Emerging Scholars Exchange Program
    Parker B. Francis Foundation2021Parker B. Francis Fellow
    Pulmonary Fibrosis Foundation2019Pulmonary Fibrosis Foundation Scholar

    Collapse Overview 
    Collapse overview
    Dr. Farrand is an Assistant Professor in the Division of Pulmonary, Critical Care, Sleep, Allergy and Sleep Medicine. She is attending physician in the Interstitial Lung Disease Program and on the Pulmonary Consult Service.

    Dr. Farrand's scholarship focuses on defining, assessing and improving the health care quality, safety and outcomes for individuals with interstitial lung disease. She collaborates closely with colleagues in ILD, health services research, implementation science and clinical informatics to support a multidisciplinary research program that aims to integrate digital health interventions to improve the delivery of chronic lung disease care.

    Collapse Research 
    Collapse research activities and funding
    Implementing Telomere Length Testing in Fibrotic Interstitial Lung Disease: Defining a Real World Strategy
    Marcus Program in Precision Medicine Innovation Oct 1, 2024 - Sep 30, 2025
    Remote Evaluation and Surveillance of Patients with Interstitial Lung Disease (RESPOND-ILD): Transforming ILD Care Delivery with Remote Monitoring
    NIH K23HL175213Sep 1, 2024 - Jul 31, 2029
    Role: Principal Investigator
    Leveraging Real World Data to Advance Interstitial Lung Disease Care Delivery
    Boehringer Ingelheim Jan 1, 2024 - Dec 31, 2026
    Role: PI
    Description: Our central hypothesis is that a universal data-driven machine learning model trained on large epidemiological populations will enhance our ability to identify and treat patients with interstitial lung disease. Specifically, these methods will 1) improve the identification of prevalent ILD cases in general adult populations, 2) identify real-world practice gaps in ILD diagnosis and management and characterize their associations with outcomes.
    The Future of ILD Care Delivery: Overcoming Barriers to Telehealth with Remote Monitoring
    Doris Duke Charitable Foundation Sep 1, 2022 - Aug 31, 2025
    Role: PI
    Description: The COVID-19 pandemic catalyzed the integration of telehealth into ILD healthcare delivery models, affording patients with reduced mobility and specialty care needs increased access to providers. However, providers are unable to evaluate disease activity and progression during telehealth visits - major barriers to the sustainable adoption of telehealth in ILD. This grant will develop implementation strategies for an ILD remote patient monitoring program using a combination of readily available digital health tools that can track disease activity and progression
    The Future of Telehealth in Interstitial Lung Disease
    CHEST Foundation Oct 1, 2020 - Oct 1, 2022
    Role: PI
    Improving Delivery of Evidence-Based Care in Idiopathic Pulmonary Fibrosis
    NIH/NHLBI Aug 6, 2020 - Aug 5, 2023
    Role: PI
    Harnessing the Power of the Electronic Medical Record in Interstitial Lung Disease
    Nina Ireland Program in Lung Health Mar 1, 2020 - Feb 28, 2022
    Role: PI
    Closing the Evidence Gap in ILD: The Use of Real World Observational Cohorts to Understand the Natural History of Fibrotic Lung Disease
    Pulmonary Fibrosis Foundation Oct 1, 2019 - Sep 30, 2021
    Role: PI
    Clinical practice patterns and healthcare resource utilization in acute exacerbation of idiopathic pulmonary fibrosis: using real world data to bridge the evidence gap
    NIH F32HL143920Jul 17, 2018 - Jun 30, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Incidence, Prevalence, and Mortality of Interstitial Lung Diseases in Alberta, Canada: A Population-based Study. Ann Am Thorac Soc. 2025 Mar 11. Johannson KA, Liu Z, Southern DA, Kalluri M, Gershon AS, Farrand E, Grant-Orser A, Fisher JH. PMID: 40068156.
      View in: PubMed   Mentions:    Fields:    
    2. Remote Patient Monitoring for Managing Interstitial Lung Disease: A Mixed Methods Process Evaluation. CHEST Pulmonary. 2025. Gillet G, Shah RJ, DeDent AM, Farrand E. View Publication.
    3. Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis. Chest. 2024 Dec; 166(6):1487-1496. Suen AO, Bischoff K, Iyer AS, Radhakrishnan K, Fenton C, Singer JP, Sudore RL, Kotwal A, Farrand E. PMID: 39186972; PMCID: PMC11745200.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Phage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease. ACR Open Rheumatol. 2024 Sep; 6(9):568-580. Upadhyay V, Yoon YM, Vazquez SE, Velez TE, Jones KD, Lee CT, Law CS, Wolters PJ, Lee S, Yang MM, Farrand E, Noth I, Strek ME, Anderson MS, DeRisi JL, Sperling AI, Shum AK. PMID: 38952015; PMCID: PMC11506559.
      View in: PubMed   Mentions: 2  
    5. Steroid therapy in acute exacerbation of fibrotic interstitial lung disease. Respirology. 2024 09; 29(9):795-802. Koshy K, Barnes H, Farrand E, Glaspole I. PMID: 38825348.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis. Chest. 2024 Jun; 165(6):1435-1443. Mullin ML, Fernandez G, Marinescu DC, Zheng B, Wong AW, Assayag D, Fisher JH, Johannson KA, Khalil N, Kolb M, Manganas H, Marcoux V, Morisset J, Min B, Farrand E, Ryerson CJ. PMID: 38128609.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. National Prevalence of Social Isolation and Loneliness in Adults with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 12; 20(12):1709-1717. Suen AO, Iyer AS, Cenzer I, Farrand E, White DB, Singer J, Sudore R, Kotwal A. PMID: 37463307; PMCID: PMC10704233.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    8. Digital outcome measures in pulmonary clinical trials. Curr Opin Pulm Med. 2023 07 01; 29(4):322-327. Farrand E, Swigris JJ. PMID: 37191175.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Machine-Learning Algorithm to Improve Cohort Identification in Interstitial Lung Disease. Am J Respir Crit Care Med. 2023 05 15; 207(10):1398-1401. Farrand E, Gologorskaya O, Mills H, Radhakrishnan L, Collard HR, Butte AJ. PMID: 36943196; PMCID: PMC10595454.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Extracting patient-level data from the electronic health record: Expanding opportunities for health system research. PLoS One. 2023; 18(3):e0280342. Farrand E, Collard HR, Guarnieri M, Minowada G, Block L, Lee M, Iribarren C. PMID: 36897886; PMCID: PMC10004557.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Addressing health disparities through implementation science-a need to integrate an equity lens from the outset. Implement Sci. 2022 01 31; 17(1):13. Kerkhoff AD, Farrand E, Marquez C, Cattamanchi A, Handley MA. PMID: 35101088; PMCID: PMC8802460.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    12. Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease. Chest. 2022 05; 161(5):1320-1329. Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Sadatsafavi M, Shapera S, To T, Wilcox PG, Collard HR, Ryerson CJ. PMID: 34788669.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    13. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax. 2022 01; 77(1):9-10. DeDent AM, Farrand E. PMID: 34510014.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    14. Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems. Clin Chest Med. 2021 06; 42(2):287-294. Farrand E, Limper AH. PMID: 34024404.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Strategies for forming effective women's groups. Clin Teach. 2021 Apr; 18(2):126-130. Santhosh L, Harleman E, Venado A, Farrand E, E Gilbreth M, Keenan BP, Thompson VV, Shah RJ. PMID: 33058547.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients. Chest. 2021 01; 159(1):219-227. Farrand E, Iribarren C, Vittinghoff E, Levine-Hall T, Ley B, Minowada G, Collard HR. PMID: 32717266; PMCID: PMC7803939.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    17. Is corticosteroid use truly not associated with improved outcomes in AE-IPF? - Reply. Respirology. 2020 06; 25(6):659-660. Farrand E, Collard HR. PMID: 32307799.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF. Respirology. 2020 06; 25(6):629-635. Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR. PMID: 31846126.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    19. Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data. Am J Respir Crit Care Med. 2019 05 01; 199(9):1061-1065. Farrand E, Anstrom KJ, Bernard G, Butte AJ, Iribarren C, Ley B, Martinez FJ, Collard HR. PMID: 30452876.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer. J Hosp Med. 2017 07; 12(7):580-584. Farrand E, Shah R, Collard H. PMID: 28699950.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study. Crit Care. 2014 Feb 27; 18(1):R38. Abrams D, Javidfar J, Farrand E, Mongero LB, Agerstrand CL, Ryan P, Zemmel D, Galuskin K, Morrone TM, Boerem P, Bacchetta M, Brodie D. PMID: 24571627; PMCID: PMC4056162.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    22. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012 Sep; 57(9):2362-70. Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J, Barasch JM, Nickolas TL. PMID: 22562534; PMCID: PMC3979299.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    23. Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. Liver Transpl. 2012 Apr; 18(4):461-7. Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS. PMID: 22467547; PMCID: PMC3674870.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency. Transplantation. 2011 Jun 15; 91(11):1254-60. Verna EC, Farrand ED, Elnaggar AS, Pichardo EM, Balducci A, Emond JC, Guarrera JV, Brown RS. PMID: 21617588.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Erica's Networks
    Concepts (111)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.